表紙
市場調査レポート

世界の核酸検査市場

Nucleic Acid Testing/NAT Market: Global Opportunities and Business Expansion Strategies for Instrument and Reagent Suppliers

発行 Venture Planning Group 商品コード 231459
出版日 ページ情報 英文 1398 Pages
納期: 即日から翌営業日
価格
本日の銀行送金レート: 1USD=101.51円で換算しております。

Local License: 同一事業所内

Back to Top
世界の核酸検査市場 Nucleic Acid Testing/NAT Market: Global Opportunities and Business Expansion Strategies for Instrument and Reagent Suppliers
出版日: ページ情報: 英文 1398 Pages
概要

当レポートでは、世界の主要国(フランス・ドイツ・イタリア・日本・スペイン・英国・米国)における核酸検査市場について調査分析し、世界市場と技術概要、各国市場の現状と今後10年間の将来予測を提供するほか、主な製品開発機会、市場参入戦略などを検証し、主要企業プロファイルも含め、概略以下の構成でお届けいたします。

イントロダクション

世界市場と技術概要

  • DNAシーケンシング
  • DNAおよびRNAプローブ技術
  • 検出技術
  • 装置レビュー
  • バイオチップ:ゲノセンサー、マイクロアレイ、ラボオンチップ
  • ファーマコゲノミクス
  • 主な応用
    • 微生物/感染症
    • 癌の検査
    • 遺伝子疾患
    • 法医学検査
    • 実父確定検査/HLA型決定
  • コスト分析
  • 競合/補完技術
  • 償還問題
  • 世界市場分析
    • ビジネス環境
    • 市場構造
    • 市場規模・成長率

フランス

  • エグゼクティブサマリー
  • ビジネス環境
  • 市場構造
  • 市場規模・成長率・主要サプライヤーの売上と市場シェア

ドイツ

  • エグゼクティブサマリー
  • ビジネス環境
  • 市場構造
  • 市場規模・成長率・主要サプライヤーの売上と市場シェア

イタリア

  • エグゼクティブサマリー
  • ビジネス環境
  • 市場構造
  • 市場規模・成長率・主要サプライヤーの売上と市場シェア

日本

  • エグゼクティブサマリー
  • ビジネス環境
  • 市場構造
  • 市場規模・成長率・主要サプライヤーの売上と市場シェア

スペイン

  • エグゼクティブサマリー
  • ビジネス環境
  • 市場構造
  • 市場規模・成長率・主要サプライヤーの売上と市場シェア

英国

  • エグゼクティブサマリー
  • ビジネス環境
  • 市場構造
  • 市場規模・成長率・主要サプライヤーの売上と市場シェア

米国

  • エグゼクティブサマリー
  • ビジネス環境
  • 市場構造
  • 市場規模・成長率・主要サプライヤーの売上と市場シェア

主な製品開発の機会

分散型検査製品の設計基準

代替的な市場浸透戦略

潜在的な市場参入障壁とリスク

競合プロファイル

付録

図表

このページに掲載されている内容は最新版と異なる場合があります。詳細はお問い合わせください。

目次
Product Code: VPNAT19493

This unique seven-country report, 1,398-page report is designed to help current suppliers and potential market entrants identify and evaluate major business opportunities emerging in the NAT market during this decade. 

Highlights

- Business and technological trends in seven major markets
- Five- and ten-year test volume and sales forecasts
- Market shares of leading competitors
- Feature comparison of major analyzers
- Profiles of market players and start-up firms developing innovative technologies
   and products
- Specific product and business opportunities for instrument and consumable suppliers.

Rationale

The NAT market is unquestionably the most rapidly growing segment of the in vitro diagnostics industry.  The next five years will witness significant developments in reagent systems and automation, as well as introduction of a wide range of new products that will require innovative marketing approaches.  The rate of market penetration into routine clinical laboratories, however, will depend on the introduction of cost-effective and automated systems with amplification methods.

In order to successfully capitalize on the opportunities presented by the NAT market, many companies are already exploiting new molecular technologies as corporate strategic assets, managed in support of business and marketing strategies.  Integrating new technology planning with business and corporate strategies will be one of the most challenging tasks for diagnostic companies during the next ten years.

Geographic Coverage

- France
- Germany
- Italy
- Japan
- Spain
- UK
- USA

Worldwide Market Overview

- Laboratories performing DNA sequencing and  NAT
by country and market segment.

- Five-year test volume and sales projections by country.

Market Segmentation Analysis

- Sales and market shares of major suppliers of NAT
reagent kits and components.

- Ten-year test volume and sales forecasts for major
applications, including:

- Infectious Diseases     - Forensic Testing
- Cancer                       - Paternity Testing/HLA Typing
- Genetic Diseases        - Others

- Ten-year test volume and sales projections for over 30
NAT assays.

- A comprehensive analysis of the sequencing market,
by country and laboratory segment, including:

- Industrial        - Academic
- Government   - Commercial

- Detailed market segmentation analysis, including
review of the market dynamics, trends, structure, size,
growth and major suppliers, by country.

Product/Technology Review

- Comparison of leading NAT
analyzers from Abbott, Beckman Coulter, BD, Bio-Rad,
Gen-Probe, Roche, Tecan and other suppliers.

- Extensive review of NAT technologies,
test formats, detection methodologies, trends
in testing automation and over 30 target/signal
amplification methods, including:

- PCR     - bDNA
- SDA     - NASBA
- TMA    - SSSR, and others
- LCR

- Worldwide listings of companies, universities and
research centers developing new NAT
technologies and products.

Competitive Assessments

- Extensive strategic assessments
of major suppliers and emerging market entrants,
including their sales, product portfolios, marketing
tactics, collaborative arrangements and new technologies/products
in R&D.

- Comprehensive listings of companies developing and
marketing NAT products, by test and
application.

Opportunities and Strategic Recommendations

- Specific new product development opportunities
with potentially significant market appeal during
the next ten years.

- Design criteria for new products.

- Alternative market penetration strategies.

- Potential market entry barriers and risks.

- Business planning issues and concerns.

Methodology

This report is based on a combination of primary and secondary information sources, including interviews with laboratory directors and executives of leading diagnostic companies and start-up firms developing innovative technologies and products in the U.S., five major European countries and Japan.

In addition to primary sources of information, a comprehensive review of the most recent technical and business publications, manufacturer product
and financial literature, as well as VPGMarketResearch’s proprietary data base was conducted.

Contains 1,398 pages and 194 tables

Table of Contents

Introduction

Worldwide Market And Technology Overview

A. DNA Sequencing

  • 1. Introduction
  • 2. Sequencing Methods
  • 3. Autoradiography
  • 4. The Human Genome Project
  • 5. Sequencing Automation
  • 6. Image Scanners
  • 7. Fluorescent Detection
  • 8. Gene Profiling
  • 9. Gene Expression
  • 10. Polymorphism Screening
  • 11. Protein Interaction Networks

B. DNA And RNA Probe Technology

  • 1. Basic Principles
  • 2. Probe Preparation
  • 3. The DNA Probe Test
    • a. Sample Preparation
    • b. Hybridization
    • c. Separation
    • d. Detection/Measurement
  • 4. Test Formats
    • a. Filter Hybridization
    • b. Southern Blot
    • c. Northern Blot
    • d. In Situ Hybridization
    • e. Others
  • 5. Labeling Techniques
  • 6. Amplification Methods
    • Polymerase Chain Reaction
      • Temperature Cyclers
      • PCR Variations
        • Immuno-PCR
        • QC-PCR
        • DAP-PCR
    • Strand Displacement Activation
    • TMA
    • Ligase Chain Reaction
    • Branched DNA
      • Hybridization Protection Assay
    • Nucleic-Acid Sequence-Based Amplification
    • Self-Sustained Sequence Replicase
    • Others
      • Ampliprobe
      • CAR
      • CAS
      • CPT
      • Dendritic Polymer Technology
      • ISO-CR
      • LAT
      • Probe Networks
      • RAMP
      • Repair Chain Reaction
      • Rolling Circles
      • Sequence Independent Gene Amplification
      • Sequence Initiation Reaction
      • SISPA
      • Solid Phase Amplification

C. Detection Technologies

  • 1. Radioactive Methods
    • a. Overview
    • b. Major Isotopes
      • P-32
      • S-35
      • H-3
      • I-125
  • 2. Non-Isotopic Methods
    • a. Enzymatic Labels
    • b. Chemical Labeling
      • Indirect Chemical Labeling
      • Direct Chemical Labeling
  • c. Fluorescence
  • d. Chemiluminescence
  • e. Electrical Conductivity

D. Instrumentation Review

  • 1. Abbott LCx
  • 2. Beckman Coulter/Biomek FK
  • 3. Becton Dickinson SDA
  • 4. Bio-Rad GeneScope
  • 5. Gen-Probe Tigris
  • 6. Roche Cobas Amplicor
  • 7. Tecan LS Series

E. Biochips: Genosensors, Microarrays, and Labs-on-the-Chip

  • Liquid Transportation and Mixing
  • Separation
  • Reaction
  • Detection

F. Pharmacogenomics

G. Major Applications

  • 1. Microbiology/Infectious Diseases
    • a. Overview
    • b. Major Infectious Diseases
      • AIDS
      • Structure and Composition
      • Classification
      • AIDS Origins
      • Animal Lentivirus Systems
      • Virus Receptors
      • HIV Infections in Humans
        • Pathogenesis and Pathology
      • CD4T Lymphocytes and Memory Cells
      • Monocytes and Macrophages
      • Lymphoid Organs
      • Neural Cells
      • Viral Coinfections
        • Clinical Findings
      • Plasma Viral Load
      • Pediatric AIDS
        • Neurologic Disease
        • Opportunistic Infections
        • Cancer
      • Immunity
        • Virus Isolation
        • Serology
        • Viral Nucleic Acid/Antigen Detection
      • Epidemiology
        • Worldwide Spread of AIDS
        • United States
        • Routes of Transmission
      • DNA Probes
        • Overview
        • Quantitative PCR
        • In Situ PCR
        • Needed Improvements
      • Viral Load/Drug Resistance Testing
      • Genotype and Phenotype Testing
      • Blood Banking Considerations
    • Adenovirus
      • Background
      • Diagnostic Tests
      • Vaccines and Drugs
      • Adeno-Associated Viruses (AAV)
    • Anthrax/Bacillus Anthracis
      • Background
      • Diagnostic Tests
      • Vaccines and Drugs
    • Babesiosis
      • Background
    • BEA and Other Bartonella Diseases
      • Background
      • Diagnostic Tests
      • Vaccines and Drugs
    • Chagas Disease
      • Background
    • Campylobacter
      • Background
      • Diagnostic Tests
        • Culture Identification
      • Vaccines and Drugs
    • Chlamydia
      • Background
        • Chlamydia psittaci
        • Chlmaydia pneumoniae
        • Chlamydia trachomatis
      • Diagnostic Tests
      • Vaccines and Drugs
    • Creutzfeldt-Jakob's Disease
      • Background
      • Blood Transmission
      • Diagnostic Tests
      • Major Commercial and Academic Players
        • Bayer
        • Disease Sciences/Bio Tec Global
        • Imperial College School of Medicine
        • Ortho-Clinical Diagnostics
        • Pall
        • ProMetic Life Sciences
        • Proteome Sciences/Idexx
        • Q-One Biotech
        • Serono
        • U.S. Agricultural Research Service
      • Drugs
      • Vaccines
    • Cytomegalovirus
      • Background
        • Chorioretinitis
        • Gastrointestinal
        • Central Nervous System Disease
      • Diagnostic Tests
      • Vaccines and Drugs
    • Ebola Virus
      • Background
        • Epidemiology
        • Clinical Syndromes
      • Diagnostic Tests
      • Vaccines and Drugs
    • EchoVirus
      • Background
        • Acute Aseptic Meningitisis
        • Encephalitis
        • Exanthems
        • Respiratory Disease
        • Myopericarditis
        • Neonatal Infections
      • Diagnostic Tests
      • Vaccines and Drugs
    • Encephalitis
      • Background
      • Diagnostic Tests
      • Vaccines and Drugs
    • Enteroviruses
      • Background
      • Diagnostic Tests
        • Viral Isolation and Identification
        • Antibody Tests
      • Vaccines and Drugs
    • Epstein-Barr Virus
      • Background
      • Diagnostic Tests
      • Vaccines and Drugs
    • Gonorrhea
      • Background
      • Diagnostic Tests
      • Vaccines and Drugs
    • Hepatitis
      • Hepatitis A
      • Hepatitis B
        • Structure and Composition
        • Replication
      • Hepatitis C
      • Hepatitis D (Delta)
      • Hepatitis E
      • Hepatitis G
      • Hepatitis Infections Pathology
      • Clinical Findings
      • Laboratory Tests
        • Hepatitis A
        • Hepatitis B
        • Hepatitis C
        • Hepatitis D
        • Hepatitis E
      • Virus-Host Immune Reactions
      • Epidemiology
        • Hepatitis A
        • Hepatitis B
        • Hepatitis C
        • Hepatitis D (Delta)
      • Vaccines and Drugs
    • Herpes Simplex Virus
      • Background
      • Diagnostic Tests
      • Vaccines and Drugs
    • Legionella
      • Background
      • Diagnostic Tests
      • Vaccines and Drugs
    • Lyme Disease
      • Background
        • Clinical Description
        • Clinical Case Definition
        • Laboratory Criteria for Diagnosis
        • Case Classification
      • Diagnostic Tests
      • Vaccines and Drugs
    • Malaria
    • Mycoplasma
      • Background
        • Ureaplasma Urealyticum & Mycoplasma
    • Hominis
      • Diagnostic Tests
      • Vaccines and Drugs
    • Papillomaviruses/HPV
      • Background
        • HPV in Cancer
        • Cervical Neoplasm
      • Diagnostic Tests
      • Vaccines and Drugs
        • Prevention
    • Parvovirus B19
      • Background
        • Microbiology
        • Epidemiology
        • Clinical Syndromes
        • Erythema Infectiosum (Slapped Cheek)
        • Adult Polyarthropathy
        • Transient Aplastic Crisis
        • Transient Pancytopenia
        • Red Cell Aplasia in Immunocompromised
        • Perinatal Infections
      • Diagnostic Test
      • Vaccines and Drugs
    • Pneumonia
      • Background
      • Diagnostic Tests
      • Vaccines and Drugs
    • Polyomaviruses
      • Background
      • Diagnostic Tests
      • Vaccines and Drugs
    • Salmonellosis
      • Background
      • Diagnostic Tests
      • Vaccines and Drugs
    • Shigellosis
      • Background
      • Diagnostic Tests
      • Vaccines and Drugs
    • Streptococci
      • Background
      • Diagnostic Tests
      • Vaccines and Drugs
        • Group A Streptococci
        • Group B Streptococci
    • Toxoplasmosis
      • Background
      • Diagnostic Tests
      • Vaccines and Drugs
    • Tuberculosis
      • Background
      • Diagnostic Tests
        • Microscopic Characteristics
        • Cultural Characteristics
        • Skin Tests
        • MDRTB
      • Vaccines and Drugs
    • West Nile Virus
      • Background
        • Clinical Syndromes
      • Diagnostic Tests
      • Vaccines and Drugs
    • Yersinia
      • Background
      • Diagnostic Tests
      • Vaccines and Drugs
    • c. Antibiotic Susceptibility
  • 2. Cancer Testing
    • a. Overview
    • b. Major Cancer Types
      • Prostate
      • Lung
      • Colon and Rectum
      • Breast
      • Skin
      • Uterine
      • Leukemia
      • Oral
    • c. Oncogenes
      • Abl/abl-bcr
      • AIB1
      • BCL-2
      • BRCA1
      • CD44
      • C-fos
      • C-myb
      • C-myc
      • CYP17
      • Erb-B
      • HPC1
      • N-myc
      • P40
      • P51
      • P53
      • PIK3CA
      • PTI-1
      • Ras
      • Reg
      • Sis
      • Src
  • 3. Genetic Diseases
    • a. Overview
    • b. Nucleic Acid Amplification
    • c. Chromosome Imaging
    • d. Genomics Technologies
    • e. Proteomics Technologies
    • f. Current Pharmacogenomic Tests
    • g. Future Pharmacogenomic Testing
    • h. Major Diseases
      • Achondroplasia
      • Autosomal Dominant Polycystic Kidney Disease
      • Cancer
      • Cosmetogenomics
      • Cystic Fibrosis
      • Down's Syndrome
      • Duchenne and Becker Muscular Dystrophy
      • Factor V (Leiden)
      • Factor IX Deficiency
      • Fragile X Syndrome
      • Heart Disease
      • Hemochomatosis
      • Hemophilia
      • Huntington's Disease
      • Maternal-Fetal Incompatibility
      • Multiple Endocrine Neoplasia
      • Phenylketonuria (PKU)
      • Polycystic Kidney Disease (PKD)
      • Prenatal Screening
      • Retinitis Pigmentosa
      • Retinoblastoma
      • Sickle Cell Anemia
      • Spinal Muscular Atrophy
      • Vitamin B12 Metabolism
    • i. Social Issues and Concerns
  • 4. Forensic Testing
    • a. Overview
    • b. Multilocus and Single Locus Probes
      • Multilocus Probes
      • Single Locus Probes
      • PCR and RFLP
    • c. The FBI
    • d. DNA Profile Data Banks
      • U.S.A.
      • U.K.
    • e. Judicial Implementation
    • f. Major Crime Categories
    • g. Factors Contributing to the DNA Probe
    • Market Expansion
      • Technology Availability
      • Use of Hair as Evidence
    • h. Wildlife Forensics
  • 5. Paternity Testing/HLA Typing
  • 6. Other Applications
    • a. Disease Susceptibility Testing
    • b. Cardiovascular Diseases
    • c. Diabetes
    • d. Alzheimer's Disease
    • e. Periodontal Disease
    • f. Plasma Purification
    • g. Organ Transplantation
    • h. Water Contamination
    • i. Other

H. Competing/complementing Technologies

  • 1. Monoclonal Antibodies/Immunoassays
  • 2. RNA Probes
  • 3. Two-Dimensional Electrophoresis
  • 4. Flow Cytometry

I. Worldwide Market Overview

  • 1. Business Environment
  • 2. Market Structure
  • 3. Market Size and Growth

France

  • A. Executive Summary
  • B. Business Environment
  • C. Market Structure
  • D. Market Size, Growth And Major Suppliers'Sales And Market Shares

Germany

  • A. Executive Summary
  • B. Business Environment
  • C. Market Structure
  • D. Market Size, Growth And Major Suppliers'Sales And Market Shares

Italy

  • A. Executive Summary
  • B. Business Environment
  • C. Market Structure
  • D. Market Size, Growth And Major Suppliers'Sales And Market Shares

Japan

  • A. Executive Summary
  • B. Business Environment
  • C. Market Structure
  • D. Market Size, Growth And Major Suppliers'Sales And Market Shares

Spain

  • A. Executive Summary
  • B. Business Environment
  • C. Market Structure
  • D. Market Size, Growth And Major Suppliers'Sales And Market Shares

U.K.

  • A. Executive Summary
  • B. Business Environment
  • C. Market Structure
  • D. Market Size, Growth And Major Suppliers'Sales And Market Shares

U.S.A.

A. Executive Summary

B. Business Environment

  • 1. Health Care Expenditures
  • 2. Cost Consciousness
  • 3. Reimbursement
  • 4. Industry Consolidation
  • 5. Managed Care
    • a. PPO
    • b. HMO
  • 6. Hospitals
  • 7. Admissions
  • 8. Length of Stay
  • 9. Industry Diversification
  • 10. Physician Demographics
  • 11. Population Aging
    • a. Chronic Illness
    • b. Disease Incidence
    • c. Susceptibility to Iatrogenesis
    • d. Multiple Illness Cases
  • 12. Laboratory Regulations
  • 13. FDA Reform

C. Market Structure

  • 1. Hospitals
  • 2. Commercial/Private Laboratories
  • 3. Blood Banks

D. Market Size, Growth and Major Suppliers' Sales and Market Shares

Major Product Development Opportunities

  • A. Instrumentation
  • B. Reagent Kits and Test Systems/panels
  • C. Computers, Software and Automation
  • D. Auxiliary Products

Design Criteria For Decentralized Testing Products

Alternative Market Penetration Strategies

  • A. Internal Development
  • B. Collaborative Arrangements
  • C. University Contracts
  • D. Distribution Strategies For Decentralized Testing Markets
    • 1. Marketing Approaches
    • 2. Product Complexity
    • 3. Customer Preference
    • 4. Established Suppliers
    • 5. Emerging Suppliers
    • 6. Major Types Of Distributors
    • 7. Market Segmentation

Potential Market Entry Barriers And Risks

  • A. Market Maturity
  • B. Cost Containment
  • C. Competition
  • D. Technological Edge And Limitations
  • E. Patent Protection
  • F. Regulatory Constraints
  • G. Decentralized Testing Market Challenges

Competitive Profiles

  • Abbott
  • Affymetrix
  • Agilent
  • Applied Gene Technologies
  • Arca
  • Beckman Coulter/Danaher
  • Becton Dickinson
  • Biokit
  • BioMerieux
  • Bio-Rad
  • Biotest
  • Caliper
  • Cepheid
  • Decode
  • Diadexus
  • Eiken
  • Enzo
  • Exact Sciences
  • Fujirebio
  • Gen-Probe
  • Hologic
  • Illumina
  • Innogenetics/Solvay
  • Kreatech
  • Li-Cor Biosciences
  • Life Technologies
  • Monogram Biosciences
  • Myriad Genetics
  • Nanogen/Elitech
  • Novartis
  • Orchid CellMark
  • Ortho-Clinical Diagnostics
  • Proteome Sciences
  • Qiagen
  • Roche
  • Scienion
  • Sequenom
  • Shimadzu
  • Siemens
  • Sierra Molecular
  • Takara Bio
  • Tecan Group

Appendixes

  • Appendix I: Major Universities and Research Centers Developing NAT Technology
  • Appendix II: Glossary of Terms
  • Appendix III: Currency Exchange Rates

List of Tables

  • Major Companies Developing or Marketing AIDS NAT And Other Direct Identification Tests
  • Major Companies Developing or Marketing Adenovirus NAT And Other Direct Identification Tests
  • Major Companies Developing or Marketing Campylobacter NAT And Other Direct Identification Tests
  • Major Companies Developing or Marketing Chlamydia NAT And Other Direct Identification Tests
  • Major Companies Developing or Marketing CMV Molecular Diagnostic And Other Direct Identification Tests
  • Major Companies Developing or Marketing EBV Molecular Diagnostic And Other Direct Identification Tests
  • Major Companies Developing or Marketing Gonorrhea NAT And Other Direct Identification Tests
  • Major Companies Developing or Marketing Hepatitis NAT And Other Direct Identification Tests
  • Major Companies Developing or Marketing Herpes NAT And Other Direct Identification Tests
  • Major Companies Developing or Marketing Legionella NAT And Other Direct Identification Tests
  • Major Companies Developing or Marketing Lyme Disease NAT And Other Direct Identification Tests
  • Major Companies Developing or Marketing Mycoplasma NAT And Other Direct Identification Tests
  • Major Companies Developing or Marketing Papilloma Virus NAT And Other Direct Identification Tests
  • Major Companies Developing or Marketing Pneumonia NAT And Other Direct Identification Tests
  • Major Companies Developing or Marketing Salmonella NAT And Other Direct Identification Tests
  • Major Companies Developing or Marketing Shigella NAT And Other Direct Identification Tests
  • Major Companies Developing or Marketing Streptococci NAT And Other Direct Identification Tests
  • Major Companies Developing or Marketing Toxoplasmosis NAT And Other Direct Identification Tests
  • Major Companies Developing or Marketing Tuberculosis NAT And Other Direct Identification Tests
  • Oncogenes Potential Application in Cancer Diagnosis
  • Major Companies Developing or Marketing Cancer NAT Tests
  • Major Companies Developing or Marketing NAT Assays For Genetic Diseases
  • Worldwide, Laboratories Performing DNA Sequencing By Country
  • Worldwide, NAT Market Potential Laboratory Universe by Country
  • Worldwide, NAT Test Volume Forecast By Country
  • Worldwide, NAT Market Forecast by Country
  • Summary Table France, NAT Test Volume And Sales Forecast by Major Application
  • France, Laboratories Performing DNA Sequencing By Market Segment
  • France, NAT Market Potential Laboratory Universe by Market Segment
  • France, NAT Test Volume Forecast By Major Application
  • France, Major Infectious Disease Molecular Diagnostics Test Volume Forecast
  • France, Infectious Disease Screening NAT Volume Forecast
  • France, NAT Market Forecast By Major Application
  • France, Infectious Disease Screening NAT Reagent Market Forecast by Test
  • France, NAT Market By Major Supplier
  • France, HIV/Hepatitis NAT Market Reagent Sales By Major Supplier
  • Summary Table Germany, NAT Test Volume And Sales Forecast by Major Application
  • Germany, Laboratories Performing DNA Sequencing by Market Segment
  • Germany, NAT Market Potential Laboratory Universe by Market Segment
  • Germany, NAT Test Volume Forecast By Major Application
  • Germany, Major Infectious Disease Molecular Diagnostics Test Volume Forecast
  • Germany, Infectious Disease Screening NAT Volume Forecast
  • Germany, NAT Market Forecast By Major Application
  • Germany, Infectious Disease Screening NAT Reagent Market Forecast by Test
  • Germany, NAT Market by Major Supplier
  • Germany, HIV/Hepatitis NAT Market Reagent Sales by Major Supplier
  • Summary Table Italy, NAT Test Volume And Sales Forecast by Major Application
  • Italy, Laboratories Performing DNA Sequencing by Market Segment
  • Italy, NAT Market Potential Laboratory Universe by Market Segment
  • Italy, NAT Test Volume Forecast By Major Application Italy, Major Infectious NAT Test Volume Forecast
  • Italy, Infectious Disease Screening NAT Volume Forecast Italy, NAT Market Forecast By Major Application
  • Italy, Infectious Disease Screening NAT Reagent Market Forecast by Test
  • Italy, NAT Market By Major Supplier
  • Italy, HIV/Hepatitis NAT Market By Major Supplier
  • Summary Table Japan, NAT Test Volume And Sales Forecast by Major Application
  • Japan, Laboratories Performing DNA Sequencing by Market Segment
  • Japan, NAT Market Potential Laboratory Universe by Market Segment
  • Japan, NAT Test Volume Forecast By Major Application
  • Japan, Major Infectious Disease NAT Test Volume Forecast
  • Japan, Infectious Disease Screening NAT Volume Forecast
  • Japan, NAT Market Forecast By Major Application
  • Japan, Infectious Disease Screening Nat Reagent Market Forecast by Test
  • Japan, NAT Market By Major Supplier
  • Japan, HIV/Hepatitis NAT Market Reagent Sales by Major Supplier
  • Summary Table Spain, NAT Test Volume And Sales Forecast by Major Application
  • Spain, Laboratories Performing DNA Sequencing by Market Segment
  • Spain, NAT Market, Potential Laboratory Universe by Market Segment
  • Spain, NAT Test Volume Forecast by Major Application
  • Spain, Major Infectious Disease NAT Test Volume Forecast
  • Spain, Infectious Disease Screening NAT Volume Forecast
  • Spain, NAT Market Forecast By Major Application
  • Spain, Infectious Disease Screening Nat Reagent Market Forecast by Test
  • Spain, NAT Market By Major Supplier
  • Spain, HIV/Hepatitis NAT Market Reagent Sales by Major Supplier
  • Summary Table U.K., NAT Test Volume And Sales Forecast by Major Application
  • U.K., Laboratories Performing DNA Sequencing by Market Segment
  • U.K., NAT Market Potential Laboratory Universe by Market Segment
  • U.K., NAT Test Volume Forecast By Major Application
  • U.K., Major Infectious Disease Molecular Diagnostics Test Volume Forecast
  • U.K., Infectious Disease Screening NAT Volume Forecast
  • U.K., NAT Market Forecast By Major Application
  • U.K., Infectious Disease Screening NAT Reagent Market Forecast by Test
  • U.K., NAT Market by Major Supplier Summary Table U.S.A., NAT Test Volume And Sales Forecast by Major Application
  • U.S.A., Laboratories Performing DNA Sequencing by Market Segment
  • U.S.A., NAT Market, Potential Laboratory Universe by Market Segment
  • U.S.A., NAT Test Volume Forecast By Major Application
  • U.S.A., Major Infectious Disease NAT Test Volume Forecast
  • U.S.A., Infectious Disease Screening NAT Volume by Test Forecast
  • U.S.A., NAT Market Forecast By Major Application
  • U.S.A., Infectious Disease Screening Nat Reagent Market Forecast by Test
  • U.S.A., NAT Market by Major Supplier
  • U.S.A., HIV/Hepatitis C NAT Market Reagent Sales By Major Supplier
  • U.S.A., West Nile Virus NAT Market Reagent Sales By Major Supplier
Back to Top